ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q3SCImago #15,493Subscription

Current Drug Discovery Technologies

Identifier (ISSN):1570-1638(Print)/1875-6220(Online)
•
Publisher:Bentham
Clarivate JCR Index Advisory: Not Indexed in Latest JCR
Clarivate Impact Factor (IF 2024)
N/A
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Current Drug Discovery Technologies

WoS Q1
000002023
Annual Impact Factor Metric
Current (2023):0
Scopus SJR & RankScopus Q3
0.353
#15,493

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
55

55 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation RateN/A
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
43articles/year
0% Gold OA•0% Original Research

Aims & Scope

Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.

Topics Covered (Recognized by AI)
Biology93.1%Chemistry82%Medicine79.7%Biochemistry73.3%Genetics65.4%Internal medicine50.3%Organic chemistry47.2%Pharmacology41%Physics38.8%Bioinformatics34%Psychology30.6%Gene27.3%Pathology26.6%Psychiatry25.4%Immunology23.6%Computer science23.5%Computational biology20.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF—
Articles / Year43
Total Citations4
2025
IF—
Articles / Year72
Total Citations132
2024
IF—
Articles / Year49
Total Citations147
2023
IF0
Articles / Year63
Total Citations255
2022
IF—
Articles / Year43
Total Citations255

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #15,493Scopus Q3SCImago Profile
Scopus Coverage:2004-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.353

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.04

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,727 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations263
3-Year Documents133
Citable Documents130

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
Updating
Minor Category (Specific Field):
Updating
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Drug Discovery Technologies (ISSN: 1570-1638) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Bentham in United Arab Emirates. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.353 (Q3), an H-index of 55.

The journal enforces rigorous peer evaluation with an annual output of approximately 43 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,727 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Bentham
Publication Language
English
Frequency
Periodic
Indexing & Databases
ScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: bf1f00bc-096d-45c3-9d1e-f8ac4d3f7c56
Database Updated: 2026-09-29